Tatemoto K, Mann M J, Shimizu M
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305.
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1174-8. doi: 10.1073/pnas.89.4.1174.
We report the synthesis of receptor antagonists of neuropeptide Y (NPY) by a strategy based on synthesis of mixtures of analogs and the subsequent isolation and identification of receptor antagonists from these mixtures. After screening a series of mixtures of NPY analogs by using an NPY antagonist assay, two potent receptor antagonists, designated PYX-1 and PYX-2, were isolated from an antagonist-containing mixture. Structural analysis revealed these analogs to be Ac-[3-(2,6-dichlorobenzyl)Tyr27, D-Thr32]NPY-(27-36) amide and Ac-[3-(2,6-dichlorobenzyl)Tyr27,36,D-Thr32]NPY-(27-36) amide, respectively. The receptor antagonists inhibited release of intracellular calcium elicited by NPY in human erythroleukemia cells and displaced 3H-labeled NPY from NPY receptors in rat brain membrane. The approach of screening and identifying useful analogs from synthetic mixtures may significantly reduce the time and resources previously required for development of receptor antagonists.
我们报告了基于合成类似物混合物并随后从这些混合物中分离和鉴定受体拮抗剂的策略来合成神经肽Y(NPY)受体拮抗剂。通过使用NPY拮抗剂测定法筛选了一系列NPY类似物混合物后,从含拮抗剂的混合物中分离出两种强效受体拮抗剂,命名为PYX - 1和PYX - 2。结构分析表明,这些类似物分别为Ac - [3 - (2,6 - 二氯苄基)Tyr27, D - Thr32]NPY - (27 - 36)酰胺和Ac - [3 - (2,6 - 二氯苄基)Tyr27,36,D - Thr32]NPY - (27 - 36)酰胺。这些受体拮抗剂抑制了人红白血病细胞中NPY引发的细胞内钙释放,并从大鼠脑膜中的NPY受体上置换了3H标记的NPY。从合成混合物中筛选和鉴定有用类似物的方法可能会显著减少以前开发受体拮抗剂所需的时间和资源。